Next Article in Journal
PRIMA-1 and PRIMA-1Met (APR-246): From Mutant/Wild Type p53 Reactivation to Unexpected Mechanisms Underlying Their Potent Anti-Tumor Effect in Combinatorial Therapies
Next Article in Special Issue
The Epithelial-to-Mesenchymal Transition in Cancer
Previous Article in Journal
Synchrotron-Based Pencil Beam Scanning Nozzle with an Integrated Mini-Ridge Filter: A Dosimetric Study to Optimize Treatment Delivery
Previous Article in Special Issue
The Epithelial-to-Mesenchymal Transition in Breast Cancer: Focus on Basal-Like Carcinomas
Review

Regulation of EMT in Colorectal Cancer: A Culprit in Metastasis

by 1 and 1,2,*
1
Division of Hematology and Oncology, Department of Medicine, Comprehensive Cancer Center, University of Alabama at Birmingham, Birmingham, AL 35233, USA
2
Birmingham Veterans Affairs Medical Center, Birmingham, AL 35233, USA
*
Author to whom correspondence should be addressed.
Cancers 2017, 9(12), 171; https://doi.org/10.3390/cancers9120171
Received: 9 November 2017 / Revised: 5 December 2017 / Accepted: 5 December 2017 / Published: 16 December 2017
(This article belongs to the Special Issue The Epithelial-to-Mesenchymal Transition (EMT) in Cancer)
Epithelial to mesenchymal transition (EMT) is a process during which cells lose their epithelial characteristics, for instance cell polarity and cell–cell contact, and gain mesenchymal properties, such as increased motility. In colorectal cancer (CRC), EMT is associated with an invasive or metastatic phenotype. In this review, we discuss recent studies exploring novel regulation mechanisms of EMT in CRC, including the identification of new CRC EMT regulators. Upregulation of inducers can promote EMT, leading to increased invasiveness and metastasis in CRC. These inducers can downregulate E-cadherin and upregulate N-cadherin and vimentin (VIM) through modulating EMT-related signaling pathways, for instance WNT/β-catenin and TGF-β, and EMT transcription factors, such as zinc finger E-box binding homeobox 1 (ZEB1) and ZEB2. In addition, several microRNAs (miRNAs), including members of the miR-34 and miR-200 families, are found to target mRNAs of EMT-transcription factors, for example ZEB1, ZEB2, or SNAIL. Downregulation of these miRNAs is associated with distant metastasis and advanced stage tumors. Furthermore, the role of EMT in circulating tumor cells (CTCs) is also discussed. Mesenchymal markers on the surface of EMT CTCs were found to be associated with metastasis and could serve as potential biomarkers for metastasis. Altogether, these studies indicate that EMT is orchestrated by a complicated network, involving regulators of different signaling pathways. Further studies are required to understand the mechanisms underlying EMT in CRC. View Full-Text
Keywords: EMT; colorectal cancer; metastasis EMT; colorectal cancer; metastasis
Show Figures

Figure 1

MDPI and ACS Style

Vu, T.; Datta, P.K. Regulation of EMT in Colorectal Cancer: A Culprit in Metastasis. Cancers 2017, 9, 171. https://doi.org/10.3390/cancers9120171

AMA Style

Vu T, Datta PK. Regulation of EMT in Colorectal Cancer: A Culprit in Metastasis. Cancers. 2017; 9(12):171. https://doi.org/10.3390/cancers9120171

Chicago/Turabian Style

Vu, Trung, and Pran K. Datta 2017. "Regulation of EMT in Colorectal Cancer: A Culprit in Metastasis" Cancers 9, no. 12: 171. https://doi.org/10.3390/cancers9120171

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Back to TopTop